Search results
This Is a Huge Sigh of Relief for Novo Nordisk Investors
Motley Fool via Yahoo Finance· 2 hours agoOzempic is the top product today, but the Food and Drug Administration (FDA) approved it for ...
Column: Fears about 'Ozempic babies' show how woeful U.S. women's healthcare really is
Los Angeles Times· 3 hours agoThe historic failure of medical research to acknowledge that women’s bodies differ from men’s has a...
How the CFOs of Eli Lilly and Novo Nordisk are coping with ‘unprecedented demand’ for weight-loss...
Fortune· 2 hours agoIndianapolis-based Eli Lilly (no. 142 on the Fortune 500) is the maker of Mounjaro, classified as Type 2 diabetes drug but which has led to weight loss ...
Eli Lilly soars 8% after Q1 earnings reveal surging popularity for its Zepbound weight-loss drug
Business Insider via Yahoo Finance· 3 days agoZepbound is the new weight loss injection from Eli Lilly. It's the same drug that's in Mounjaro for...
Why a legal fight against the manufacturers of Ozempic, Mounjaro, and other diabetes and weight-loss...
Philly.com· 1 day agoThe patients live all over the country, but the lawsuits that play out in a Philadelphia courtroom...
Weight loss drug wins 25,000 new US users a week
BBC via Yahoo Finance· 20 hours agoThe surge reflects scorching demand for the medicine which, alongside sister diabetes drug Ozempic, has been hailed as revolutionary and helped to...
Promising new study with diabetes drug for people with Parkinson's disease
KTBS Shreveport· 3 days agoApril is Parkinson's Disease awareness month, and there is a newdrug that has promising results for...
Denmark to restrict Ozempic, other GLP-1 drugs, to treat type 2 diabetes
Reuters via Yahoo News· 2 days agoIn 2023, 50% of new patients suffering from type 2 diabetes began treatment with a reimbursed GLP-1 ...
Amgen Soars as CEO Touts Experimental Obesity Drug’s Progress
Bloomberg via Yahoo Finance· 2 hours ago(Bloomberg) -- Amgen Inc.’s shares soared after its chief executive officer said he was “very...
Novo Nordisk's Ozempic Stock Rally Is Hitting a Wall
The Wall Street Journal· 2 hours agoThe Danish maker of the Ozempic and Wegovy drugs has seen its share price fall 7% over the past two days. If maintained through the closing bell in...